The fact that there's only been one new gout medication approved in the last 40 years creates interest in articles on prospective new gout drugs such as canakinumab and lenisurad.
Vancouver, BC (PRWEB) September 06, 2011
Gouty arthritis patients now have a new online resource designed specifically for them. The new site, http://www.colchicine.ca, scours the web for news and views of interest to those with gout to provide them with a "one stop-shop" for advice and information.
"People are busy," says colchicine.ca editor, Lynn Woods, "They don't have time to surf the web after work to see what's interesting or important in the world of gout treatment, so we do it for them. Some of our posts are entertaining, most are educational, and many contain valuable up-to-the-minute information on gout."
Woods describes the new site, which launched in June and is seeing increasing traffic daily, as "informal and informative." "We try to approach gout from a positive perspective," says Woods, "We believe that, armed with the right information, patients can learn to control and even avoid gout attacks."
A quick look through the site showcases its diversity: explanations of gout symptoms, causes, and treatment; advice on dealing with painful gout flare ups; information on natural gout remedies like frankincense, cherries, baking soda and goutweed; articles on treating gout with diet; and up-to-date news on gout medication (including a new intravenous gout drug for sufferers who haven't obtained relief from current gout treatments).
One of the most popular articles on the gout site is about the recent FDA colchicine controversy. Gout sufferers and their physicians were shocked and angered when the price of colchicine skyrocketed after the FDA ordered generic colchicine off the market in favor of name brand Colcrys. The article describes the history behind the FDA's decision, the resulting public outcry, and how gout patients can still obtain inexpensive generic colchicine from Canada.
Other often-read articles are "Ten Things You May Not Know About Gout", and "Cherries Prove an Effective Gout Medication". The fact that there's only been one new gout medication approved in the last 40 years creates interest in articles on prospective new gout drugs such as canakinumab ("Anticipated Gout Medication Unlikely to Win FDA Approval"), and lenisurad ("Experimental Gout Medication Outperforms Allopurinal").
Gout is considered the most painful form of arthritis. The incidence of gout has doubled since the 1960s, and it now affects an estimated 8.3 million Americans, most of them men. Woods stresses the significance of gout patients practicing good self care. "It's vitally important that gout patients educate themselves about and control their condition," she says, "Untreated gout can not only be excruciatingly painful, it can also be permanently disabling and disfiguring."
Visit colchicine.ca for more information on gout and colchicine.